Stockreport

Anteris Technologies Looks Bullish If DurAVR's PARADIGM Delivers [Seeking Alpha]

Anteris Technologies Global Corp.  (AVR) 
PDF AVR's PARADIGM pivotal trial is the central catalyst. This will compare DurAVR against commercial valves across 85 sites in the US, Europe, and Canada. I believe that [Read more]